基本信息
浏览量:9
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
In 1973, Akira Endo of Sankyo Company in Tokyo discovered mevastatin, pioneering research into a new class of molecules known as statins, now a hugely successful class of drugs targeting the lowering of cholesterol.
In the mid-1960s, Endo completed a two-year appointment at the Albert Einstein College of Medicine. While in New York, he learned about the connection between high cholesterol and coronary heart disease which led to his hypothesis that inhibiting HMG-CoA reductase, a key enzyme in the process of synthesizing cholesterol in the liver, could decrease cholesterol levels. At Sankyo, Endo tested thousands of microbes before ultimately discovering mevastatin, which lowered LDL cholesterol dramatically in patients. Eventually, Endo was invited by Merck in the United States to present on mevastatin, and some time later, Merck introduced the first commercial statin in 1987.
Endo, who received B.A. and Ph.D. degrees from Tohoku University in Japan, currently serves as Director of Biopharm Research Laboratories and is Distinguished Professor Emeritus at Tokyo University of Agriculture and Technology. His honors include the 2006 Japan Prize and the 2008 Lasker-DeBakey Clinical Medical Research Award.
In the mid-1960s, Endo completed a two-year appointment at the Albert Einstein College of Medicine. While in New York, he learned about the connection between high cholesterol and coronary heart disease which led to his hypothesis that inhibiting HMG-CoA reductase, a key enzyme in the process of synthesizing cholesterol in the liver, could decrease cholesterol levels. At Sankyo, Endo tested thousands of microbes before ultimately discovering mevastatin, which lowered LDL cholesterol dramatically in patients. Eventually, Endo was invited by Merck in the United States to present on mevastatin, and some time later, Merck introduced the first commercial statin in 1987.
Endo, who received B.A. and Ph.D. degrees from Tohoku University in Japan, currently serves as Director of Biopharm Research Laboratories and is Distinguished Professor Emeritus at Tokyo University of Agriculture and Technology. His honors include the 2006 Japan Prize and the 2008 Lasker-DeBakey Clinical Medical Research Award.
研究兴趣
论文共 9 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NATURE BIOMEDICAL ENGINEERING (2024)
DEVELOPMENTAL CELLno. 19 (2023): 1819-+
The American Journal of Medicineno. 10 (2020): e594-e595
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn